Portfolio (Quarterly)
Guide ↗
Connor, Clark & Lunn Investment Management Ltd.
· CIK 0001596800| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 581 | BANF | BANCFIRST CORP | Financial Services | 2,110.0 | $224K | 0.00% | +208.0 | +10.9% | $106.02 | +6.5% |
| 582 | COTY | COTY INC | Consumer Defensive | 65,009.0 | $200K | 0.00% | +16K | +31.6% | $3.08 | -11.0% |
| 583 | HYLN | HYLIION HOLDINGS CORP | Consumer Cyclical | 107,953.0 | $199K | 0.00% | +94K | +680.6% | $1.84 | +81.0% |
| 584 | AVAL | GRUPO AVAL ACCIONES Y VALORE | Financial Services | 44,412.0 | $180K | — | +15K | +49.5% | $4.05 | +34.8% |
| 585 | KOS | KOSMOS ENERGY LTD | Energy | 192,424.0 | $175K | — | +169K | +730.3% | $0.91 | +226.2% |
| 586 | AMPY | AMPLIFY ENERGY CORP NEW | Energy | 37,818.0 | $173K | — | +8K | +26.5% | $4.57 | +5.5% |
| 587 | — | ATOSSA THERAPEUTICS INC | — | 266,010.0 | $157K | — | +17K | +7.0% | $0.59 | — |
| 588 | ORMP | ORAMED PHARMACEUTICALS INC | Healthcare | 43,735.0 | $125K | — | +15K | +54.9% | $2.85 | +68.8% |
| 589 | HRTX | HERON THERAPEUTICS INC | Healthcare | 94,009.0 | $122K | — | +10K | +12.3% | $1.30 | -75.5% |
| 590 | CATO | CATO CORP NEW | Consumer Cyclical | 24,172.0 | $75K | — | +5K | +27.1% | $3.09 | -5.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Financial Services
23.7%
Technology
22.0%
Basic Materials
12.8%
Energy
9.8%
Industrials
8.3%
Consumer Cyclical
8.2%
Healthcare
5.7%
Communication Services
3.1%
Utilities
2.7%
Consumer Defensive
2.4%